Watch CDNA. Know when insiders buy.
One email the day a filing lands. Free.
CDNA
CareDx, Inc.
50.03
−0.28 −0.56%
USD · close Sep 9
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
65
PASS · shorts 65
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $2.6BP/E 24.2DIV YIELD —FCF YIELD —REV TTM $458.1M +34.4%NET INCOME $111M +90.9%NET CASH $373.6M52W 13.33 – 52.36SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $131.9M | +52.2% | — | $113.2M | $110.6M | — | 2.07 | $30.6M | $1.9M | $28.7M | Jul 30 |
| Q1 2026 · Mar 31 | $117.7M | +39.0% | — | $1.2M | $2.8M | — | 0.05 | $4.3M | $3.8M | $514K | Jul 30 |
| Q4 2025 · Dec 31derived | $108.4M | +25.2% | — | −$6M | −$4.1M | −104.7% | -0.08 | $21.4M | — | — | Feb 25 |
| Q3 2025 · Sep 30 | $100.1M | +20.7% | — | −$246K | $1.7M | — | 0.03 | $37.4M | — | — | Nov 4 |
| Q2 2025 · Jun 30 | $86.7M | −6.1% | — | −$11.1M | −$8.6M | — | -0.16 | $9.9M | $1M | $8.9M | Jul 30 |
| Q1 2025 · Mar 31 | $84.7M | +17.5% | — | −$13.4M | −$10.4M | — | -0.19 | −$26.6M | $1.6M | −$28.2M | Jul 30 |
| Q4 2024 · Dec 31derived | $86.6M | +32.0% | — | $84.4M | $87.7M | — | 1.60 | $21.9M | — | — | Feb 25 |
| Q3 2024 · Sep 30 | $82.9M | +23.4% | — | −$13.7M | −$10.6M | — | -0.20 | $12.5M | — | — | Nov 4 |
| Q2 2024 · Jun 30 | $92.3M | — | — | −$7.3M | −$4.6M | — | -0.09 | $18.9M | — | — | Nov 4 |
| Q1 2024 · Mar 31 | $72M | — | — | −$22.6M | −$19.9M | — | -0.38 | −$15.3M | — | — | Nov 4 |
| Q4 2023 · Dec 31derived | $65.6M | — | — | −$122.6M | −$118.1M | — | -2.20 | −$8.4M | — | — | Feb 25 |
| Q3 2023 · Sep 30 | $67.2M | — | — | −$28.8M | −$23.5M | — | -0.43 | −$10.2M | — | — | Nov 4 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $379.8M | — | −$30.8M | −$21.4M | -5.6% | -0.40 | $42M | — | — | $87.8M | — |
| FY2024 · to Dec 31 | $333.8M | — | $40.8M | $52.5M | 15.7% | 0.93 | $38M | — | — | $522K | — |
| FY2023 · to Dec 31 | $280.3M | — | −$203.4M | −$190.3M | -67.9% | -3.54 | −$18.4M | — | — | $27.5M | — |
| FY2022 · to Dec 31 | $321.8M | — | −$77.2M | −$76.6M | -23.8% | -1.44 | −$25.2M | — | — | $642K | — |
| FY2021 · to Dec 31 | $296.4M | — | −$29.7M | −$30.7M | -10.3% | -0.59 | −$19.3M | — | — | $0 | — |
| FY2020 · to Dec 31 | $192.2M | — | −$22.5M | −$18.7M | -9.7% | -0.40 | $33.4M | — | — | $0 | — |
Every number comes from CareDx, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.